Abstract
In the present study, a new antibacterial bone graft substitute has been developed for repairing bone defects and inhibiting related infections at the same time. Calcium sulphate hemihydrate (CSH) was introduced into nanohydroxyapatite/collagen (nHAC) to prepare a self-settingin situbone repair materials. The nHAC/CSH was used as a carrier of vancomycin (VCM) for anti-infection and the treatment of osteomyelitis. The VCM/nHAC/CSH composite was a porous scaffold with porosity of 38.8% and the compressive mechanical strength was about 4.8 MPa. The final setting time was about 15~20 min. The inhibition ratio of VCM/nHAC/CSH was more than 99.8% and the distinct inhibition zone of 18 mm was formed in Staphylococcus aureus bacterium incubation dish with VCM/nHAC/CSH disc in the center of agar matrix for 16 hours of incubation. After incubating 17 days at 37in vitro, the concentration of vancomycin in elution fluild was around 12 μg/mL. Therefore, the VCM/nHAC/CSH bone substitute presents ideal self-setting antibacterial, cytocompatibility, sustained release properties and has great potential applications for the treatment of bone defect-related infection in orthopedic surgeries.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
